Items of recent pandemic news: Antihistamines may help some long Covid; J&J pauses manufacturing vaccine; FDA authorizes Eli Lilly’s injectable monoclonal; how boosters wane; and a further delay in shots for the youngest children. Plus a frippery. Quote of the … Continue reading →
Items of recent pandemic news: the US government buys more of Merck’s molnupiravir; a possible shortage of syringes looms next year; how Covid-19 affects the heart; and a pause in the administration’s vaccine mandate for companies. Plus a frippery. Biden’s … Continue reading →
Items of recent pandemic news: Merck will allow other countries to make molnupiravir; why it’s better to be vaccinated than just recovered; an antidepressant that improves Covid-19 outcomes; and the CDC’s vote on vaccines for kids. Plus a frippery. CDC … Continue reading →
Items of recent pandemic news you may have missed: Delta Air Lines’ strong encouragement for vaccination; contaminated vaccine in Japan; good news on a J&J booster; and the dent approval is not making in vaccine hesitancy. Plus two fripperies. Approval … Continue reading →
Items of recent pandemic news: China will donate 2 billion doses; the unvaxxed consider shots more dangerous than Covid-19; FDA is fast-tracking full approval for Pfizer; countries and the WHO weigh booster shots; and more. Plus a frippery. 1. Pfizer … Continue reading →
Items of recent pandemic news you may have missed: Emergent gets a manufacturing green light; an antibody cocktail is authorized for prophylaxis; the nations planning to issue booster doses; and the whiplash engendered by the delta variant. Plus a frippery. … Continue reading →
Herewith a brief issue, as pandemic news has been thin over a holiday weekend. No news briefs today but of course there’s a frippery. WHO tackles naming the variants The designations given to the viral variants are not friendly; the … Continue reading →
Herewith three items of pandemic news you may have missed recently: Disparate theories of long Covid; Europe locks in 1.8 billion Pfizer doses; and the troubles attendant upon Russia’s Sputnik V vaccine. Plus news briefs and a frippery. Russia’s Sputnik … Continue reading →
Three items of pandemic news you may have missed recently: Watching the virus evolve variants in a single human; a damning report on Emergent’s vaccine manufacturing plant; and the dimming prospects for herd immunity. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Covid-19 can damage the brain without infecting it; what’s up with the blood clots; and the FDA shuts down Emergent’s Baltimore operation. Plus news briefs and a frippery. FDA … Continue reading →
Three items of pandemic news you may have missed recently: Canada is struggling; J&J is ordered to take over Emergent’s factory; and the mRNA vaccines appear safe and effective in pregnant women. Plus news briefs and a frippery. mRNA shots … Continue reading →
Three items of pandemic news you may have missed recently: Moderna can pack more doses per vial; Emergent’s big mistake; and news on vaccines for kids as young as 12. Plus news briefs and a pair of fripperies. Pfizer is … Continue reading →
Herewith a couple of items of pandemic news you may have missed: Who is helping whom with manufacturing? And the impact of US export bans in support of Pfizer on vaccine production elsewhere. Plus news briefs and a frippery. US … Continue reading →
Herewith three items of pandemic news you may have missed recently: Youyang Gu’s model of the path to herd immunity; hesitancy from several directions about Johnson & Johnson’s vaccine; and the latest on pandemic passports. Plus news briefs and a … Continue reading →
Herewith three items of pandemic news you may have missed recently: A caution for those scheduling mammograms around the time of vaccination; sterilizing immunity from vaccines; and peptides for prevention and treatment. Plus news briefs and a frippery. Peptides Dr. … Continue reading →
